A class of low-density parity-check codes constructed based on Reed-Solomon codes with two information symbols

This letter presents an algebraic method for constructing regular low-density parity-check (LDPC) codes based on Reed-Solomon codes with two information symbols. The construction method results in a class of LDPC codes in Gallager's original form. Codes in this class are free of cycles of length 4 in their Tanner graphs and have good minimum distances. They perform well with iterative decoding.     

Construction of Regular and Irregular LDPC Codes: Geometry Decomposition and Masking

Two algebraic methods for systematic construction of structured regular and irregular low-density parity-check (LDPC) codes with girth of at least six and good minimum distances are presented. These two methods are based on geometry decomposition and a masking technique. Numerical results show that the codes constructed by these methods perform close to the Shannon limit and as well as random-like LDPC codes. Furthermore, they have low error floors and their iterative decoding converges very fast. The masking technique greatly simplifies the random-like construction of irregular LDPC codes designed on the basis of the degree distributions of their code graphs     

Solution equilibria in l-glutamic acid and l-serine + iron(III) systems

Complex formation equilibria in l-glutamic acid (H2Glu) and l-serine (HSer) +iron(III) ion systems have been studied by a combination of glass electrode potentiometric and visible spectrophotometric measurements in 0.5 mol dm–3 (Na)NO3 ionic medium at 25°C. In the concentration range 1.0[Fe3+]5.0; 3.0[Glu2–]30.0 mmol dm–3 ([Glu]/[Fe]=3:1 to 30:1) and pH between 1.5 and 4.5, iron(III) and glutamic acid form the Fe(Glu)–2, Fe(Glu)+, Fe(HGlu)2+, Fe(OH)Glu, Fe2(OH)2Glu2+, Fe(OH)Glu22– complexes: and several pure hydrolytic products. Iron(III) and l-serine, beside pure hydrolytic complexes of iron(III), form the Fe(HSer)3+, Fe(Ser)2+, Fe(OH)Ser+, Fe(OH)2- Ser0, Fe(OH)Ser2 and Fe2(OH)2(Ser)2+2 complexes, over a broad concentration range of serine to iron ([Ser]/[Fe]=5:1 to 500:1), from pH 1.5 to 4.0. The stability constants of the complexes are given and their formation mechanism is suggested. The possible structure of the complexes, in solution, is discussed.     

Solution equilibria between ethylenediamine-N,N'-di-3-propionate and some transition metal(II) ions

Solution equilibria between the ligand ethylenediamine-N,N'-di-3-propionate (eddp(2-)) and copper(II), nickel(II) or cobalt(II) ions were studied by glass electrode pH-metric and spectrophotometric measurements in 0.1 M NaCl ionic medium at 298.0+/-0.2 K. In the concentration limits 1.0相似文献   

Validation of an HPLC method for the determination of fleroxacin and its photo-degradation products in pharmaceutical forms

HPLC determination of fleroxacin in dosage forms was carried out using either reversed-phase column YMC pack ODS-AQ or Supelco LC Hisep shielded hydrophobic phase column, with UV detection at 280 nm. The mobile phase for ODS column consisted of 50:50:0.5 v/v/v and for Hisep column 15:85:0.5 v/v/v acetonitrile-water-triethylamine. The pH of the mobile phase was adjusted to 6.30 for ODS column and to 6.85 for Hisep column, with H3PO4. Linear response was obtained in the concentration range of fleroxacin between 0.01 and 1.30 micrograms/mL. Detection limit was 4.8 ng/mL. Recovery test in the determination of fleroxacin in "Quinodis" tablets (Hoffmann La Roche, nominal mass 400 or 200 mg) was 98-101% for both columns. The effect of the composition and pH of the mobile phase on spectra, retention time and dissociation constants of fleroxacin was discussed. The proposed method could be also used for separation of the photo-degradation products of fleroxacin. Ten degradation products were separated on the ODS-AQ column, thus confirming the suitability of the proposed method for stability study of fleroxacin in pharmaceuticals.     

Fluorescence reaction and complexation equilibria between norfloxacin and aluminium (III) ion in chloride medium

Norfloxacin, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid (NORH), reacts with aluminium(III) ion forming the strongly fluorescent complex [Al(HNOR)]³⁺, in slightly acidic medium. The complex shows maximum emission at 440 nm with excitation at 320 nm. The fluorescence intensity is enhanced upon addition of 0.5% sodium dodecylsulphate. Fluorescence properties of the Al-NOR complex were used for the direct determination of trace amounts of NOR in serum. The linear dependence of fluorescence intensity on NOR concentration, at a NOR to Al concentration ratio of 1:10, was found in the concentration range 0.001–2 μg/ml NOR with a detection limit of 0.1 ng/ml. The ability of aluminium (III) ion to form complexes with NOR was investigated by titrations in 0.1 M LiCl medium, using a glass electrode, at 298 K, in the concentration range: 2 × 10⁻⁴ ≤ [Al] ≤ 8 × 10⁻⁴; 5 × 10⁻⁴ ≤ [NOR] ≤ 9 × 10⁻⁴ mol/dm³; 2.8 ≤ pH ≤ 8.3. The experimental data were explained by the following complexes and their respective stability constants, log(β ± σ): [Al(HNOR)], (14.60 ± 0.05); [Al(NOR)], (8.83 ± 0.08); [A1(OH)₃(NOR)], (−14.9 ± 0.1), as well as several pure hydrolytic complexes of A1³⁺. The structure of the [Al(HNOR)] complex is discussed, with respect to its fluorescence properties.     

Allocolchicines via intramolecular Nicholas reactions: the synthesis of NSC 51046

Biaryl propargyl acetate hexacarbonyldicobalt complexes (4) undergo Lewis acid mediated Nicholas reactions with a remote arene function to afford dibenzocycloheptyne complexes (9). Reductive decomplexation based on a hydrosilylation-protodesilylation protocol is facile, and the 1,2,3,9-tetramethoxy case can be converted to NSC 51046 ((S)-N-acetylcolchicinol methyl ether, 3).     

Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions

Fluoroquinolones (FQLs) are synthetic antibacterial agents containing a 4-oxo-1,4-dihydroquinoline skeleton. When concomintantly administered with other drugs which may contain metal ions, particularly Al(3+) (antacids, phosphate binders, vaccines etc) they may form metal-drug complexes. Pharmacokinetic studies showed that aluminium-quinolone interactions lead to reduced bio- availability and altered activity of the drug with possible development of the toxic effects of aluminum ion. Reliable speciation in Al(3+) - quinolone systems at micromolar concentration level is needed to better understand pharmaco- and toxicokinetics of the FQLs in the presence of Al. In this work, the speciation in solutions containing Al(3+) and FQL family members (fleroxacin, moxifloxacin and ciprofloxacin) was studied by electrospray mass spectrometry (ESI-MS), ESI-MS/MS, and laser desorption ionization (LDI) MS. The dominating species identified in all the three Al(3+)-FQL solutions, at ca 30-50 μmol L(-1) total Al concentration and 2:1 to 1:3 metal-to-ligand ratio in the pH range 3.0- 6.0, were the ions related to the complexes AlL(2+), AlL(2)(+) and AlL(3)(0) (L = ligand in the monodeprotonated form). Mixed protonated and hydroxo complexes were also formed at lower and higher pH values respectively and, as expected, dimeric and polymeric species were not observed in ESI spectra. LDI measurements confirmed the existence of the mononuclear complexes found by ESI, and indicated the formation of polymeric species. The ion [2Al(3+) +5(-)](+) was identified with all three FQLs. This ionic species most probably arises from Al(2)L(2) by clustering with free ligand anions. Comparison of literature potentiometric data with mass spectral data indicated good agreement between speciation schemes. The obtained results suggest the presence of strong interaction between FQLs and Al(3+) which may be important in affecting absorption of these drugs in the gastrointestinal tract.     

Ab initio protein fold prediction using evolutionary algorithms: influence of design and control parameters on performance

True ab initio prediction of protein 3D structure requires only the protein primary structure, a physicochemical free energy model, and a search method for identifying the free energy global minimum. Various characteristics of evolutionary algorithms (EAs) mean they are in principle well suited to the latter. Studies to date have been less than encouraging, however. This is because of the limited consideration given to EA design and control parameter issues. A comprehensive study of these issues was, therefore, undertaken for ab initio protein fold prediction using a full atomistic protein model. The performance and optimal control parameter settings of twelve EA designs where first established using a 15-residue polyalanine molecule-design aspects varied include the encoding alphabet, crossover operator, and replacement strategy. It can be concluded that real encoding and multipoint crossover are superior, while both generational and steady-state replacement strategies have merits. The scaling between the optimal control parameter settings and polyalanine size was also identified for both generational and steady-state designs based on real encoding and multipoint crossover. Application of the steady-state design to met-enkephalin indicated that these scalings are potentially transferable to real proteins. Comparison of the performance of the steady state design for met-enkephalin with other ab initio methods indicates that EAs can be competitive provided the correct design and control parameter values are used.     

Acid-base equilibria in substituted 4-quinolone carboxylic acid solutions

The protonation constants of some substituted 4-quinolone carboxylic acid anions (ofloxacin, pefloxacin and ciprofloxacin) were determined in lithium chloride solution of various concentrations at 293, 303 and 313 K using the pH-metric and spectrophotometric methods. The values of thermodynamic parameters (deltaG, deltaH and deltaS) for the first protonation step of these anions in 0.1M lithium chloride at 293 K, are reported. The formation of intramolecular hydrogen bonds is discussed.